196 related articles for article (PubMed ID: 19388168)
21. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs.
de Cordoba SR; Tortajada A; Harris CL; Morgan BP
Immunobiology; 2012 Nov; 217(11):1034-46. PubMed ID: 22964229
[TBL] [Abstract][Full Text] [Related]
22. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
[TBL] [Abstract][Full Text] [Related]
23. The spectrum of phenotypes caused by variants in the CFH gene.
Boon CJ; van de Kar NC; Klevering BJ; Keunen JE; Cremers FP; Klaver CC; Hoyng CB; Daha MR; den Hollander AI
Mol Immunol; 2009 May; 46(8-9):1573-94. PubMed ID: 19297022
[TBL] [Abstract][Full Text] [Related]
24. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).
Abrera-Abeleda MA; Nishimura C; Smith JL; Sethi S; McRae JL; Murphy BF; Silvestri G; Skerka C; Józsi M; Zipfel PF; Hageman GS; Smith RJ
J Med Genet; 2006 Jul; 43(7):582-9. PubMed ID: 16299065
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.
Vaziri-Sani F; Holmberg L; Sjöholm AG; Kristoffersson AC; Manea M; Frémeaux-Bacchi V; Fehrman-Ekholm I; Raafat R; Karpman D
Kidney Int; 2006 Mar; 69(6):981-8. PubMed ID: 16528247
[TBL] [Abstract][Full Text] [Related]
26. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
Licht C; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies in haemolytic uraemic syndrome (HUS).
Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
[TBL] [Abstract][Full Text] [Related]
28. Complement regulators and inhibitory proteins.
Zipfel PF; Skerka C
Nat Rev Immunol; 2009 Oct; 9(10):729-40. PubMed ID: 19730437
[TBL] [Abstract][Full Text] [Related]
29. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Iatropoulos P; Daina E; Curreri M; Piras R; Valoti E; Mele C; Bresin E; Gamba S; Alberti M; Breno M; Perna A; Bettoni S; Sabadini E; Murer L; Vivarelli M; Noris M; Remuzzi G; ;
J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
[TBL] [Abstract][Full Text] [Related]
30. Complement factor H and haemolytic uraemic syndrome.
Mathieson P
Lancet; 2002 Mar; 359(9308):801-2. PubMed ID: 11888630
[No Abstract] [Full Text] [Related]
31. Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance.
Tortajada A; Pinto S; Martínez-Ara J; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
Kidney Int; 2012 Jan; 81(1):56-63. PubMed ID: 21881555
[TBL] [Abstract][Full Text] [Related]
32. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
[TBL] [Abstract][Full Text] [Related]
33. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.
Sethi S; Fervenza FC
Semin Nephrol; 2011 Jul; 31(4):341-8. PubMed ID: 21839367
[TBL] [Abstract][Full Text] [Related]
34. The role of complement in C3 glomerulopathy.
Zipfel PF; Skerka C; Chen Q; Wiech T; Goodship T; Johnson S; Fremeaux-Bacchi V; Nester C; de Córdoba SR; Noris M; Pickering M; Smith R
Mol Immunol; 2015 Sep; 67(1):21-30. PubMed ID: 25929733
[TBL] [Abstract][Full Text] [Related]
35. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
Richards A; Kavanagh D; Atkinson JP
Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
[TBL] [Abstract][Full Text] [Related]
36. Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology.
Józsi M; Manuelian T; Heinen S; Oppermann M; Zipfel PF
Histol Histopathol; 2004 Jan; 19(1):251-8. PubMed ID: 14702193
[TBL] [Abstract][Full Text] [Related]
37. The role of defective complement control in hemolytic uremic syndrome.
Zipfel PF; Misselwitz J; Licht C; Skerka C
Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
[TBL] [Abstract][Full Text] [Related]
38. [Properdin, factor H, factor I].
Ohsawa I; Tomino Y
Nihon Rinsho; 2010 Jun; 68 Suppl 6():77-81. PubMed ID: 20942006
[No Abstract] [Full Text] [Related]
39. Complement factor H: using atomic resolution structure to illuminate disease mechanisms.
Barlow PN; Hageman GS; Lea SM
Adv Exp Med Biol; 2008; 632():117-42. PubMed ID: 19025119
[TBL] [Abstract][Full Text] [Related]
40. The role of complement Factor H in age-related macular degeneration: a review.
Donoso LA; Vrabec T; Kuivaniemi H
Surv Ophthalmol; 2010; 55(3):227-46. PubMed ID: 20385334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
